RxDoctor Payments Data

Heidi Rose, NP

Nurse Practitioner · Sacramento, CANPI 1376625582

Payments from drug & device makers

$4,730in general payments, 2019–2025

Across 267 payments — averaging $17.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$1K
  • AbbVie$806
  • Sun Pharmaceutical Industries Inc.$592
  • Sanofi$528
  • Regeneron Healthcare Solutions, Inc.$452
  • Lilly USA, LLC$393
  • plus $670 from 9 others

What the payments were for

  • Speaking & faculty fees$140%
  • Food & beverage$4,13487%
  • Education$58212%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,730 in reported general payments places this provider in the 90th percentile of 6,779 nurse practitioner providers in California.

See all nurse practitioner providers in California

Medicare billing

Part B allowed, 2024
$34,174
Medicare patients
117
Services billed
613

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TremfyaGuselkumab13$177,174
Dupixent SyringeDupilumab13$48,053
Dupixent PenDupilumab12$42,716
Ketoconazole224$3,827
Fluocinonide57$2,273
Clobetasol Propionate46$2,039
Fluorouracil25$1,622
Clindamycin Phosphate33$1,221
Metronidazole21$1,119
Triamcinolone Acetonide74$688
Betamethasone Dipropionate17$562
ValacyclovirValacyclovir Hcl18$497
Mupirocin58$363
Ciclopirox13$290
Hydrocortisone38$253

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonTremfya$1,289$177,17413 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,779 nurse practitioner providers in California.

Other nurse practitioner in Sacramento

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →